Stockscreener 앱 받기
2.505
5.47%
-0.145
Orasure Technologies Inc 주식(OSUR)의 최신 뉴스
OraSure in pact for celiac disease testing (OSUR:NASDAQ) - Seeking Alpha
OraSure Technologies (OSUR) Partners to Enhance At-Home Celiac Testing | OSUR Stock News - GuruFocus
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing - The Manila Times
Orasure technologies outlines Q2 2025 revenue guidance of $28.5M-$32.5M amid new product launches and customer expansions - MSN
OraSure Executive Resigns, Effective June 30 - Investing.com
OraSure Executive Resigns, Effective June 30 By Investing.com - Investing.com Canada
OraSure Technologies First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies Announces CPO Resignation - TipRanks
Orasure Technologies, Inc. Announces Resignation of Chief Product Officer Kathleen G. Weber Effective June 30, 2025 - marketscreener.com
Evercore ISI cuts OraSure stock price target to $3 from $4 - Investing.com Nigeria
Shareholders Will Probably Hold Off On Increasing OraSure Technologies, Inc.'s (NASDAQ:OSUR) CEO Compensation For The Time Being - simplywall.st
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus
Earnings call transcript: OraSure’s Q1 2025 beats EPS forecast, stock stable - Investing.com
OraSure Technologies Reports Q1 2025 Financial Results - TipRanks
OraSure: Q1 Earnings Snapshot - The Washington Post
OraSure reports first quarter loss, but looks forward to emerging as 'stronger enterprise' - WFMZ.com
OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OS - GuruFocus
OraSure Technologies Reports Q1 2025 Revenue Decline - TipRanks
OraSure Technologies (OSUR) Projects Q2 2025 Revenue Growth | OSUR Stock News - GuruFocus
OraSure (OSUR) Reports Q1 Revenue Slightly Above Expectations | OSUR Stock News - GuruFocus
OraSure Announces First Quarter 2025 Financial Results - The Manila Times
OraSure Technologies Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
OraSure Technologies: Historically Cheap (NASDAQ:OSUR) - Seeking Alpha
Press Release Distribution & PR Platform - ACCESS Newswire
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th - The Manila Times
OraSure Technologies, Inc. Schedules Q1 2025 Earnings Conference Call for May 7, 2025 - Nasdaq
OraSure Q1 2025 Earnings Preview: Key Financial Metrics and Live Q&A Session Coming May 7 - Stock Titan
Your Guide to Rapid Testing for Syphilis, HIV & HCV - Labroots
OraSure Technologies to Present at CL King’s 15th Annual Best Ideas Conference - marketscreener.com
GE HealthCare (GEHC) Surges 10.6%: Is This an Indication of Further Gains? - Nasdaq
Premier Biotech Increases Offerings and Global Distribution Network with Recent Acquisitions - The Joplin Globe
Drug Screening Market is Expected to Reach $19.5 billion | MarketsandMarkets™ - The Globe and Mail
OraSure Technologies (NASDAQ:OSUR shareholders incur further losses as stock declines 12% this week, taking five-year losses to 75% - Yahoo Finance
Insider Stock Buying Reaches US$761.0k On OraSure Technologies - simplywall.st
OraSure Technologies Elects Jack Kenny to the Board of Directors - marketscreener.com
OraSure Technologies, Inc. (OSUR): Insider Were Buying In Q1 2025 - Insider Monkey
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Sold by Charles Schwab Investment Management Inc. - MarketBeat
OraSure announces $40M stock buy back - Lehigh Valley Business
OraSure announces $40 million stock buyback plan By Investing.com - Investing.com Australia
OraSure announces $40 million stock repurchase program - WFMZ.com
3.32%
자본화:
|
볼륨(24시간):